Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
Advancements in the field of cellular immunotherapy have accelerated in recent years and have changed the treatment landscape for a variety of hematologic malignancies. Cellular immunotherapy strategies exploit the patient’s immune system to kill cancer cells. The successful use of CD19 chimeric ant...
Guardado en:
Autores principales: | Zhengli Xu, Xiaojun Huang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
China Anti-Cancer Association
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/96e553b7917b447ba42b7368cc8e3bf6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
por: Lara Herrera, et al.
Publicado: (2021) -
Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
por: Alessandro Allegra, et al.
Publicado: (2021) -
The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors
por: Rodion A. Velichinskii, et al.
Publicado: (2021) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Sergey Kulemzin, et al.
Publicado: (2021) -
Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
por: Erica L. Heipertz, et al.
Publicado: (2021)